Frontlight ResearchEarly access
Trial site
University of Chicago Comer Children's Hospital
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers9 trials
- Neuroblastoma8 trials
- Phase
- Phase 17 trials
- Phase 31 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting3 trials
- Lead sponsor
- New Approaches to Neuroblastoma Therapy Consortium6 trials
- Children's Hospital of Philadelphia1 trial
- Dana-Farber Cancer Institute1 trial
- Eli Lilly and Company1 trial
- Jerry Zimmerman1 trial
- and 1 more
Running trials
Active, not recruiting
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
Recruiting
Active, not recruiting
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Active, not recruiting
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Active, not recruiting
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Neuroblastoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026